Wednesday, July 8, 2026

pharma · Dermatitis, Atopic · Cancer

Janssen-Cilag Pty

Janssen-Cilag Pty trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

SYDNEY, IT HQ
118 Employees
TGA registrant Type
Company details
Status
Public
HQ
SYDNEY, IT
Employees
118
Programs
3
Drugs
24
Patents
0
Intelligence · Clinical Trials

Janssen-Cilag Pty clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to Janssen-Cilag Pty programs — each row shows trial ID, program name, phase, status, and indication.

Janssen-Cilag Pty trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for Janssen-Cilag Pty.

  1. CNTO148UCO3003 — Phase 3

    Clinical update
  2. Tramadol HCI/acetaminophen — Approved

    Clinical update
  3. Tacrolimus — Approved

    Clinical update

Trial registry

3 studies